Lab Web Site:
Yoland Smith, PhD, received his doctorate in neurobiology from Laval University, Canada, and completed his doctoral training in the Medical Research Council Unit at the University of Oxford, England.
The aim of Dr. Smith’s research is to understand the pathophysiology of Parkinson's Disease (PD) and characterize changes in the synaptic plasticity of the basal ganglia in normal and pathological conditions. To achieve these goals, the Smith lab has developed a collaborative, interdisciplinary research program that uses in vitro and in vivo anatomical, electrophysiological, pharmacological and brain imaging approaches to study the functional organization of the basal ganglia in normal nonhuman primates and in nonhuman primate models of PD. This work is complemented with behavioral studies of novel surgical and pharmacologic therapies for PD in nonhuman primates.
In July 2015, Dr. Smith was selected to serve on the Clinical Neuroplasticity and Neurotransmitters Study Section within the Center for Scientific Review at the National Institutes of Health. His term runs through June 2019. Members are selected on the basis of their demonstrated competence and achievement in their scientific discipline as evidenced by the quality of research accomplishments, publications in scientific journals and other significant scientific activities, achievements and honors. Membership on a study section represents a major commitment of professional time and energy as well as a unique opportunity to contribute to the national biomedical research effort. Study sections review grant applications submitted to the NIH, make recommendations on these applications to the appropriate NIH national advisory council or board, and survey the status of research in their fields of science. These functions are of great value to medical and allied research in this country.
View publications on PubMed